News Related to Numeric Rating Scale

Related coverage linked through entity extraction aliases.

NEXT BIOMEDICAL and NexEos Bio Reach FDA Milestones

Jul 27, 2026

NEXT BIOMEDICAL completed an FDA pre-submission review for Nexsphere-F under the TAP program. NexEos Bio received IND clearance to begin a Phase II/III trial of NTX-1024 for vernal keratoconjunctivitis, supported by positive early clinical data.

Keenova's Xiaflex Meets Phase 3 Goals in Plantar Fibromatosis, Filing Planned Before Year-End

Jul 10, 2026

Keenova's Xiaflex met its primary and secondary endpoints in a Phase 3 trial for plantar fibromatosis. The company plans to file for FDA approval before year-end. A separate real-world evidence manuscript highlighted the lack of approved nonsurgical options for the condition.